| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/28/2008 | CN100390131C Unsaturated 1-amino-alkylcyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists |
| 05/28/2008 | CN100389829C Identification method of compound for inhibiting tumour injury and medicinal compositions containing said compound |
| 05/28/2008 | CN100389821C Stabilized liquid polypeptide-containing pharmaceutical composition |
| 05/28/2008 | CN100389814C Ointment for treating nervous damage and preparation method thereof |
| 05/28/2008 | CN100389811C Wind dispelling drop pill containing amomum fruit |
| 05/28/2008 | CN100389806C Anti-fatigue health-caring capsule |
| 05/28/2008 | CN100389798C Litchi peel extract, its preparation method and purposes |
| 05/28/2008 | CN100389778C Lipase activity inhibitor containing high-molecular weight polyphenol fraction, tea extract and process for producing the same |
| 05/28/2008 | CN100389776C Use of CM101 in preparing medicine |
| 05/28/2008 | CN100389775C Total epimeddium flavone tablet and its use in preparation of medicine for relaying immunity decrepitudation |
| 05/28/2008 | CN100389773C Novel helicobacter pylori-binding substances and use thereof |
| 05/28/2008 | CN100389678C Health product for improving quality of produing sperm |
| 05/28/2008 | CN100389663C Method for preparing milk powder contg. micron additives for tonifying-Yin and nourishing of life |
| 05/27/2008 | US7378532 Anticancer agents; such as succinic acid mono-[5-(1-benzyl-1H-indazol-3-yl)-furan-2-ylmethyl]ester, sodium salt; inhibit cancer cell growth |
| 05/27/2008 | US7378529 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/27/2008 | US7378526 Cholinergic ligands at the nicotinic acetylcholine receptors; diseases related to the cholinergic system; neurodegenerative disorders; pain; antiinflammatory; diagnostic or monitoring tools using labelled forms; 3-Phenyletynyl-quinuclidin-2-ene |
| 05/27/2008 | US7378485 A compound containing a polyamide backbone bearing a plurality of ligands that are individually bound to aza nitrogen atoms loacted within the backbone and atleast one ligand is a nucleobase, a DNA intercalator or nucleobase binder |
| 05/27/2008 | US7378443 Fatty acid analogues for the treatment of cancer |
| 05/27/2008 | US7378438 Asthma; side effect reduction; converting SH groups to SNO groups of N-benzylphthalimide usingHCl and NaNO2; epoxide or thioepoxid of N-benzylphthalimide; amination; 5-{2-[(1-Yloxyl-2,2,5,5-tetramethyl-pyrrolidin-3-ylmethyl)-amino]-1-S-nitroso-ethyl}-1,1,3,3-tetramethylisoindolin-2-yloxyl, hydrochloride |
| 05/27/2008 | US7378433 N-[4-(heteroarylmethyl)phenyl]-heteroarylamines |
| 05/27/2008 | US7378431 Amide derivatives as NMDA receptor antagonists |
| 05/27/2008 | US7378430 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 05/27/2008 | US7378425 For preventing, treating and/or improving a disease against which a sigma receptor binding action and/or an acetylcholinesterase inhibitory action is efficacious |
| 05/27/2008 | US7378424 Derivatives of pyrimido[6, 1-A]isoquinolin-4-one |
| 05/27/2008 | US7378418 Azabicyclic heterocycles as cannabinoid receptor modulators |
| 05/27/2008 | US7378413 2-amino-3-(alkyl)-pyrimidone derivatives |
| 05/27/2008 | US7378412 Pharmaceutical compounds |
| 05/27/2008 | US7378404 For therapy of estrogen-deficiency-induced diseases and conditions |
| 05/27/2008 | US7378403 phosphoinositol ether lipid analogues and bioisosteres thereof;serine/threonine kinase (protein kinase B (PKB)) inhibitor; antitumor and anticarcinogenic agent; decreasing phosphorylation, increasing apoptosis in a tumor cell, and inhibiting pleckstrin homology (PH) domain binding |
| 05/27/2008 | US7378398 Administering a sulfoquinovosylacylglycerol; uterine cancer, breast cancer or pancreas adenocarcinoma cancer |
| 05/27/2008 | US7378393 Recombinant anticoagulant proteins |
| 05/27/2008 | US7378117 Method for the production of potato juice products by means of food technology |
| 05/27/2008 | US7378108 Percutaneous absorption preparation of compound having angiotensin II antagonistic activity |
| 05/27/2008 | US7378107 administering triglycerides such as triester of caprylic acid or capric acid with glycerin, used along with foods or drugs, without concerning about side effects and restrictive diets |
| 05/27/2008 | US7378077 Hydrating a leukemia patient; parenterally administering a dose samarium ethylenediaminetetramethylenephosphonic acid (EDTMP); and melphalan, busulfan, and/or cyclophosphamiide; anticarcinogenic, antitumor, and antantiproliferative agents; autoimmune, infectious , metabolic or genetic disorders |
| 05/27/2008 | CA2423357C Fused heterocyclic derivatives as phosphodiesterase inhibitors |
| 05/27/2008 | CA2384111C Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
| 05/27/2008 | CA2145641C Pseudo-adenovirus vectors |
| 05/24/2008 | CA2610638A1 Use of agomelatine to obtain drugs intended for the treatment of smith-magenis syndrome |
| 05/22/2008 | WO2008060813A2 High affinity antibody antagonists of interleukin-13 receptor alpha 1 |
| 05/22/2008 | WO2008060441A2 Stable amifostine liquid concentrate |
| 05/22/2008 | WO2008059991A1 Diagnosis and treatment of autism using cd38 |
| 05/22/2008 | WO2008059927A1 Collagen peptide composition and food or beverage containing the same |
| 05/22/2008 | WO2008059905A1 Raw material for oral product and oral product using the same |
| 05/22/2008 | WO2008059877A1 Aptamer against midkine and use thereof |
| 05/22/2008 | WO2008059870A1 Heat shock protein inducer, skin preparation for external use, food and drug containing the same, and method of producing heat shock protein inducer |
| 05/22/2008 | WO2008059867A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059866A1 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059865A1 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059819A1 Seaweed-derived immunostimulant and antiinflammatory agent |
| 05/22/2008 | WO2008059800A1 Novel polyamine derivatives |
| 05/22/2008 | WO2008058451A2 Ultrasound microbubble mediated genes delivery system |
| 05/22/2008 | WO2008058438A1 The use of ferric citrate in the manufacture of medicaments for treating blood vessel calcification |
| 05/22/2008 | WO2008058383A1 Acat inhibitors and their use in the prevention or treatment of fibrosis |
| 05/22/2008 | WO2008021550A3 Thiol-based agents for reducing toxicities associated with medical procedures employing radiographic contrast agents |
| 05/22/2008 | US20080119568 Gastrointestinal Absorption Enhancer Mediated By Proton-Coupled Transporter and Its Preparing Method |
| 05/22/2008 | US20080119562 Methods of Inducing Terminal Differentiation |
| 05/22/2008 | US20080119561 Methods for preventing or delaying catheter- based resvascularization |
| 05/22/2008 | US20080119558 Drug for Inhibiting Production of Matrix Metalloprotease-9 |
| 05/22/2008 | US20080119553 Preventive and/or therapeutic treatment of hyperlipidemia or non-insulin dependent diabetes mellitus which comprises dministering orally a polyprenyl compound 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid (NIK-333); antidiabetic and -lipemic agents |
| 05/22/2008 | US20080119547 Treating of a psychological disorder by administering a 3-Benzo[1,3]dioxol-5-yl-indan-1-yl)-dimethylamine or analogous 1,3-dithio, 1-oxa-3-thio ring derivatives; antidepressants; anxiolytic agents; post traumatic stress disorder, obsessive compulsive disorder, panic disorder, panic attacks, phobias |
| 05/22/2008 | US20080119546 Treatment of hyperproliferative conditions of body surfaces |
| 05/22/2008 | US20080119534 Benzimidazole Derivatives as Therapeutic Agents |
| 05/22/2008 | US20080119529 An epothilone derivative such as epothilone A,B,C or D with a bisphosphonate such as zoledronic acid, a platinum compound such as carboplatin or a vasculostatic compound such as vatalanib succinate; antitumor agents |
| 05/22/2008 | US20080119528 use of specific cyklolignans |
| 05/22/2008 | US20080119526 Ep2 receptor agonists |
| 05/22/2008 | US20080119523 3-[(2-{[4-(hexyloxycarbonylaminoiminomethyl) phenylamino]methyl}-1-methyl-1h-benzimidazol-5- carbonyl)pyridin-2-ylamino]propionic acid ethylester methansulfonate and its use as a medicament |
| 05/22/2008 | US20080119512 Carboxamide Derivatives as Therapeutic Agents |
| 05/22/2008 | US20080119503 Androgen receptor modulators and methods of use thereof |
| 05/22/2008 | US20080119496 7-Substituted Purine Derivatives for Immunosuppression |
| 05/22/2008 | US20080119495 Phosphodiesterase 4 inhibitors |
| 05/22/2008 | US20080119466 1-(4-Chloro-3-(trifluoro-methyl)phenyl)-3-(4-imidazo-[4,5-c]pyridin-1-ylphenyl)urea; Raf, a serine-threonine protein kinase inhibitor; Raf/MEK/ERK cascade in proliferation of human cancer cells; anticarcinogenic agent; psoriasis, atherosclerosis, chronic rheumatoid arthritis and diabetes |
| 05/22/2008 | US20080119455 {2-[3-(4-Methyl-2-[2-methypropoxy]phenyl)-ureido]-thiazol-4-yl}-acetic acid ethyl ester; glucokinase inhibitor; antidiabetic, hypoglycemic agent; activators of glucokinase |
| 05/22/2008 | US20080119454 Aryl carbonyl derivatives as therapeutic agents |
| 05/22/2008 | US20080119452 4-[(4-N,N-diethylaminocarbonyl)phenyl]-spiro[2H, 1-benzopyran-2,4'-piperidine]; non-peptidic delta opioid receptor synergistic withother active ingredients; antidepressant, anxiolytic agent; Alzheimer's Disease, age-related cognitive decline, Parkinson's Disease, AIDS, schizophrenia |
| 05/22/2008 | US20080119429 Methods and means for increasing resistance to cell damage |
| 05/22/2008 | US20080119423 isolated antisense oligonucleotide hybrids for treating pain in a mammal; biodrugs |
| 05/22/2008 | US20080119411 use of salmon calcitonin in combination with PTH for the oral administration of PTH for the treatment of osteoporosis without the potentially toxic hypercalcemic side effects |
| 05/22/2008 | US20080119410 comprising administering bactericidal/permeability-increasing protein (BPI proteins) or fragments to a patient suffering from age related macular degeneration (ARMD) |
| 05/22/2008 | US20080119408 Pth formulations for intranasal delivery |
| 05/22/2008 | US20080119403 Haparin-Binding Protein Modified with Heparan Sulfate Sugar Chains, Process for Producing the Same and Pharmaceutical Compositions Containing the Same |
| 05/22/2008 | US20080119400 Regulators of complement activation (RCA); diagnosis/therapy of complement system for autoimmune disease treatment; open reading frames; point mutations; membrane cofactor/decay accelerating factor/factor H |
| 05/22/2008 | US20080119396 TGF analogs/promoter that bind to and neutralize cystine knot-containing BMP antagonists such as the CAN subfamily of Cystine-knot proteins including sclerostin and promotes bone growth and mineralization in vivo; |
| 05/22/2008 | US20080119390 Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus |
| 05/22/2008 | US20080119388 METHODS OF USING sIP-10 TO ASSESS HCV CLEARANCE AND/OR RESPONSE TO INTERFERON THERAPY |
| 05/22/2008 | US20080119387 Contacting small molecule or polypeptide with a cell, cell extract, or purified cell components containing L41 and ribosomes, detecting whether the test composition inhibits the interaction of L41 with the ribosomes; anddetermining whether the test composition inhibits peptidyl transferase activity |
| 05/22/2008 | US20080119384 Use of TPO peptide compounds and pharmaceutical compostions in the treatment of anemia |
| 05/22/2008 | US20080118589 Pharmaceutical formulations of rhodiola crenulata and methods of use thereof |
| 05/22/2008 | US20080118578 Topical Medicaments and Methods for Photodynamic Treatment of Disease |
| 05/22/2008 | US20080118569 Biocompatible, hydrophilic, non-toxic microspheres associated with stem cells and a biocompatible carrier and are not capable of being displaced, or eliminated by the lymphatic system; tissue-targeted therapy, tissue repair |
| 05/22/2008 | US20080118568 For perfumes, silicones, waxes, flavors, vitamins and fabric softening agents; cosmetics; laundering; improved delivery efficiency |
| 05/22/2008 | US20080118563 Preparation of Chitin and Derivatives Thereof For Cosmetic and Therapeutic Use |
| 05/22/2008 | US20080118539 Anti-biocontaminant products and processes for making the same |
| 05/22/2008 | US20080118525 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 05/22/2008 | US20080118512 Antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK |
| 05/22/2008 | US20080118509 For directly inducing cell death without immune effector cells; antigens |
| 05/22/2008 | US20080118506 Humanized Anti-Factor D Antibodies and Uses Thereof |
| 05/22/2008 | US20080118504 Pattern recogniton receptor for use in identifying modulator for treatment and prevention of sepsis, graft vs host, autoimmune, inflammatory and respiratory disorders |
| 05/22/2008 | US20080118502 Using metalloproteinase modulators as stimulatory tools in tissue regeneration; tissue engineering |
| 05/22/2008 | US20080118495 Using avian cells as screening tools in monitoring and/or identifying viricidal agents |